Erika Carmel-Tech Ltd (TLV:ERKA)

Market Cap	22.29M
Revenue (ttm)	39.63M
Net Income (ttm)	-11.45M
Shares Out	104.17M
EPS (ttm)	-0.11
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	51,686
Average Volume	176,477
Open	23.40
Previous Close	20.90
Day's Range	20.90 - 23.40
52-Week Range	15.00 - 30.30
Beta	1.20
RSI	53.58
Earnings Date	Nov 18, 2025

About Erika Carmel-Tech

Erika Carmel-Tech Ltd develops, manufactures, markets, distributes, and sells the B-Cure laser products in Israel and internationally. It offers B-Cure Laser Classic, a non-invasive and safe medical device for the treatment of chronic and acute pain for home use; and B-Cure Laser Pro, a clinically proven, non-invasive and safe medical device for treatment of both acute and chronic conditions. The company treats achilles tendon inflammation, burns, carpal tunnel syndrome, finger joint pain, fibromyalgia, hip pain, post-dental treatment, lower ba...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 2007
• Employees: 44
• Stock Exchange: Tel Aviv Stock Exchange
• Ticker Symbol: ERKA

Financial Performance

In 2024, Erika B-Cure Laser's revenue was 37.96 million, an increase of 27.03% compared to the previous year's 29.88 million. Losses were -9.47 million, -50.73% less than in 2023.